Programed cell death protein 1 (PD-1) is a cell surface receptor. PD-1 and its ligand PD-L1 are crucial immune checkpoints to downregulate T cell activation, tolerance and immunopathology. Several types of cancer cells overexpress PD-L1 in order to escape from the PD-1/PD-L1 immunosurveillance mechanism.
Human PD-L1 inhibitor V is a peptide-based molecule. It binds to human PD-1 and inhibits PD-1/PD-L1 binding. This peptide, hPDL-1 inhibitor V has anchor residues (underlined), LDYVNRRKMYQ that influence binding of hPD-L1 to hPD-1. Developing inhibitors specifically blocking the PD-1/PD-L1 pathway has become a popular approach toward cancer treatment.
CAT No: X21209
Synonyms/Alias: Human PD-L1 inhibitor V;CHEMBL5276309;2815311-61-4;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C65H104N20O18S |
M.W/Mr. | 1485.7 |
Sequence | One Letter Code:LDYVNRRKMYQ Three Letter Code:H-Leu-Asp-Tyr-Val-Asn-Arg-Arg-Lys-Met-Tyr-Gln-OH |
InChI | InChI=1S/C65H104N20O18S/c1-33(2)28-39(67)53(92)81-48(32-51(90)91)60(99)83-46(30-36-15-19-38(87)20-16-36)61(100)85-52(34(3)4)62(101)84-47(31-50(69)89)59(98)78-42(12-9-26-75-65(72)73)56(95)77-41(11-8-25-74-64(70)71)55(94)76-40(10-6-7-24-66)54(93)79-43(23-27-104-5)57(96)82-45(29-35-13-17-37(86)18-14-35)58(97)80-44(63(102)103)21-22-49(68)88/h13-20,33-34,39-48,52,86-87H,6-12,21-32,66-67H2,1-5H3,(H2,68,88)(H2,69,89)(H,76,94)(H,77,95)(H,78,98)(H,79,93)(H,80,97)(H,81,92)(H,82,96)(H,83,99)(H,84,101)(H,85,100)(H,90,91)(H,102,103)(H4,70,71,74)(H4,72,73,75)/t39-,40-,41-,42-,43-,44-,45-,46-,47-,48-,52-/m0/s1 |
InChI Key | TWQFYTLFODMZIW-WIRYOQIKSA-N |
References | 1. Bardhan K., et.al, Front Immunol 7(550), (2016); 2. Li Q., et.al, Oncotarget 7(40), 64967-64976 (2016); 3. D'Errico G., et.al, Clin Transl Med 6(1), 3-12 (2017) |
1. High fat diet and GLP-1 drugs induce pancreatic injury in mice
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.